Cargando…

Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma

Hepatocellular carcinoma is a common malignant tumor with high mortality. Its malignant proliferation, invasion, and metastasis are closely related to the cellular immune function of the patients. NKG2D is a key activated and type II membrane protein molecule expressed on the surface of almost all N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jian, Li, Cun-Di, Sun, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094213/ https://www.ncbi.nlm.nih.gov/pubmed/32075046 http://dx.doi.org/10.3390/biom10020301

Ejemplares similares

The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma
por: Sheppard, Sam, et al.
Publicado: (2017)

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
por: Frazao, Alexandra, et al.
Publicado: (2019)

NKG2D(+)CD4(+) T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
por: Yang, Di, et al.
Publicado: (2017)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
por: Tan, Ge, et al.
Publicado: (2023)

New prospects on the NKG2D/NKG2DL system for oncology
por: Ullrich, Evelyn, et al.
Publicado: (2013)

Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy
por: Ding, Hui, et al.
Publicado: (2018)

Molecular Bases for the Regulation of NKG2D Ligands in Cancer
por: Huergo-Zapico, Leticia, et al.
Publicado: (2014)

Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma
por: Liu, Yu-Fan, et al.
Publicado: (2022)

A signature based on NKG2D ligands to predict the recurrence of hepatocellular carcinoma after radical resection
por: Chen, Dongbo, et al.
Publicado: (2022)

The Role of NKG2D in Vitiligo
por: Plaza-Rojas, Lourdes, et al.
Publicado: (2021)

Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer
por: Kaidun, Polina, et al.
Publicado: (2023)

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas
por: Hagelstein, Ilona, et al.
Publicado: (2021)

Recent Advances in Bioinformatics Reveal the Molecular Heterogeneity of Hepatocellular Carcinoma
Publicado: (2014)

How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
por: Antonangeli, Fabrizio, et al.
Publicado: (2017)

Corrigendum: The Role of NKG2D in Vitiligo
por: Plaza-Rojas, Lourdes, et al.
Publicado: (2021)

Oncolytic measles virus enhances antitumour responses of adoptive CD8(+)NKG2D(+) cells in hepatocellular carcinoma treatment
por: Chen, Aiping, et al.
Publicado: (2017)

Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
por: Zöller, Tobias, et al.
Publicado: (2018)

The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
por: Stojanovic, Ana, et al.
Publicado: (2018)

Recent advances in the imaging of hepatocellular carcinoma
por: You, Myung-Won, et al.
Publicado: (2015)

Recent Advances in Immunotherapy for Hepatocellular Carcinoma
por: Nakano, Shigeharu, et al.
Publicado: (2020)

Recent Advancements for the Treatment of Hepatocellular Carcinoma
por: Nouso, Kazuhiro
Publicado: (2023)

Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition
por: Rong, Xiao-Xiang, et al.
Publicado: (2015)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

Soluble NKG2D ligands impair CD8(+) T cell antitumor function dependent of NKG2D downregulation in neuroblastoma
por: Zhang, Yi, et al.
Publicado: (2023)

An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma
por: Mantovani, Stefania, et al.
Publicado: (2020)

TLR and NKG2D Signaling Pathways Mediate CS-Induced Pulmonary Pathologies
por: Wortham, Brian W., et al.
Publicado: (2013)

Potential of the NKG2D/NKG2DL Axis in NK Cell-Mediated Clearance of the HIV-1 Reservoir
por: Desimio, Maria G., et al.
Publicado: (2019)

The Paradoxical Role of NKG2D in Cancer Immunity
por: Sheppard, Sam, et al.
Publicado: (2018)

Leveraging NKG2D Ligands in Immuno-Oncology
por: Fuertes, Mercedes Beatriz, et al.
Publicado: (2021)

Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma
por: Aitcheson, Gabriella, et al.
Publicado: (2021)

Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
por: Niu, Zhao-Shan, et al.
Publicado: (2022)

Failure recovery of circulating NKG2D(+)CD56(dim)NK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence
por: Gao, Jian, et al.
Publicado: (2015)

Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives
por: Xu, Weiqi, et al.
Publicado: (2019)

Recent Advances in Liver Resection for Hepatocellular Carcinoma
por: Morise, Zenichi, et al.
Publicado: (2014)

Recent advances of GOLM1 in hepatocellular carcinoma
por: Yan, Jiuliang, et al.
Publicado: (2020)

Recent advances in systemic therapy for hepatocellular carcinoma
por: Zhang, Huajun, et al.
Publicado: (2022)

Recent advances in the surgical management of hepatocellular carcinoma
por: Glantzounis, Georgios K., et al.
Publicado: (2021)

Circular RNAs in hepatocellular carcinoma: Recent advances
por: Niu, Zhao-Shan, et al.
Publicado: (2022)

Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides
por: Liu, Ruiqi, et al.
Publicado: (2022)

Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
por: Shen, Chen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pa9q4d0m4vj93skv3drnfdkmcc